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Abstract
Background: Lower respiratory tract infection in children is increasingly thought to be polymicrobial in origin.
Children with symptoms suggestive of pulmonary tuberculosis (PTB) may have tuberculosis, other respiratory tract
infections or co-infection with Mycobacterium tuberculosis and other pathogens. We aimed to identify the presence
of potential respiratory pathogens in nasopharyngeal (NP) samples from children with suspected PTB.
Method: NP samples collected from consecutive children presenting with suspected PTB at Red Cross Children’s
Hospital (Cape Town, South Africa) were tested by multiplex real-time RT-PCR. Mycobacterial liquid culture and
Xpert MTB/RIF was performed on 2 induced sputa obtained from each participant. Children were categorised
as definite-TB (culture or qPCR [Xpert MTB/RIF] confirmed), unlikely-TB (improvement of symptoms without TB
treatment on follow-up) and unconfirmed-TB (all other children).
Results: Amongst 214 children with a median age of 36 months (interquartile range, [IQR] 19–66 months),
34 (16 %) had definite-TB, 86 (40 %) had unconfirmed-TB and 94 (44 %) were classified as unlikely-TB. Moraxella
catarrhalis (64 %), Streptococcus pneumoniae (42 %), Haemophilus influenzae spp (29 %) and Staphylococcus aureus
(22 %) were the most common bacteria detected in NP samples. Other bacteria detected included Mycoplasma
pneumoniae (9 %), Bordetella pertussis (7 %) and Chlamydophila pneumoniae (4 %). The most common viruses
detected included metapneumovirus (19 %), rhinovirus (15 %), influenza virus C (9 %), adenovirus (7 %),
cytomegalovirus (7 %) and coronavirus O43 (5.6 %). Both bacteria and viruses were detected in 73, 55 and 56 %
of the definite, unconfirmed and unlikely-TB groups, respectively. There were no significant differences in the
distribution of respiratory microbes between children with and without TB. Using quadratic discriminant analysis,
human metapneumovirus, C. pneumoniae, coronavirus 043, influenza virus C virus, rhinovirus and cytomegalovirus
best discriminated children with definite-TB from the other groups of children.
Conclusions: A broad range of potential respiratory pathogens was detected in children with suspected TB. There
was no clear association between TB categorisation and detection of a specific pathogen. Further work is needed
to explore potential pathogen interactions and their role in the pathogenesis of PTB.
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Background
Lower respiratory tract infection (LRTI) is a leading cause
of mortality and morbidity in children under five years,
accounting for approximately 1 million deaths in 2013
globally [1]. Pulmonary tuberculosis (PTB) is an important
cause of LRTI and may present as acute or chronic disease
[2]. TB is increasingly recognised as a primary cause or as
a comorbid condition in children hospitalized with pneu-
monia, particularly in settings endemic for human im-
munodeficiency virus (HIV) and TB [3].
Diagnosis of PTB in children is largely made based on
clinical and radiological features, which may be non-
specific. Therefore PTB cannot be easily differentiated
from other causes of acute or chronic LRTI [4]. Recent
studies have reported detection of polymicrobial infec-
tions in children with LRTI [5]. Further, PTB has in-
creasingly been reported in children presenting with
acute pneumonia; culture confirmed TB was reported in
8 % of South African children hospitalized with acute
pneumonia with no difference by HIV status [6]. A recent
meta-analysis confirmed Mycobacterium tuberculosis in
7.5 % of childhood pneumonia cases in TB endemic
areas [3].
There are limited published data on the role of other
respiratory pathogens amongst patients suspected to
have TB [7]. In Africa, only one study, conducted in
Botswana, has addressed this question amongst adult
PTB suspects. This study reported microbiologically con-
firmed TB in 118/229 (52 %); Mycoplasma pneumoniae
infection in 36/218 (17 %) and Pneumocystis jirovecii
infection in 4/141 (3 %) of PTB suspects [7]. Co-infection
with two or more pathogens was documented in 25 % of
patients [7].
In our studies of South African children hospitalised
with suspected PTB, 16 % of children hospitalised with
suspected PTB had microbiologically-confirmed PTB,
48 % were classified as unconfirmed-PTB and 37 % were
classified as unlikely-PTB (children in whom TB was ex-
cluded and who improved in the absence of TB therapy)
[8]. Approximately half of the children were treated for
PTB, including all children with definite PTB and most
with unconfirmed PTB [8]. These data raise several
questions around potential co-infections including the
extent to which these may contribute to disease or
severity in PTB, the aetiology of LRTI amongst chil-
dren with symptoms suggestive PTB and the role of
other potential respiratory pathogens in those with-
out TB.
We have recently shown [5] that specific pathogens
(including Bordetella pertussis, influenza virus, respiratory
syncyntial virus [RSV], adenovirus, parainfluenzavirus,
bocavirus) are detected significantly more frequently from
the nasopharynx (NP) of children with pneumonia than
age-matched controls, and so are likely to play an
important role in pneumonia aetiology. We therefore con-
ducted a preliminary study to investigate the diversity of
potential respiratory pathogens in the NP of children hos-
pitalised with suspected PTB.
Methods
Study population and TB testing
The population studied in this study has been previously
described [8]. Briefly, we enrolled children under 15 years
of age suspected of PTB presenting (between July 2011
and May 2012) at Red Cross War Memorial Children’s
Hospital (RCH), a specialist referral paediatric hospital
in Cape Town, South Africa. Verbal assent was obtained
from children older than seven (7) years of age and
informed consent was obtained from a parent or legal
guardian for all children.
Suspected TB was defined as having history of a cough
and one of the following: i) a household contact with TB
within the previous three months, ii) loss of weight or
failure to gain weight in the previous three months, iii) a
positive tuberculin skin test (TST) to purified protein
derivative (PPD; 2TU, PPD RT23, Staten Serum Institute,
Denmark, Copenhagen), or iv) a chest radiograph suggest-
ive of PTB. A positive skin test was defined as 5 mm or
more of transverse induration in children with HIV infec-
tion or 10 mm or more in children without HIV infection
[9]. Children were excluded if the child was on TB treat-
ment or TB prophylaxis for more than 72 h, and if they
could not be followed-up (not resident in Cape Town). All
patients with laboratory confirmed TB and those diag-
nosed with TB based on clinical and radiological criteria
were referred for TB therapy at a local clinic in ac-
cordance with South African National Guidelines [10].
Children were followed up at 1 and 3 months to assess re-
sponse to therapy or improvement without TB treatment.
All children received care in the public health system that
includes free expanded programme on immunisation
(EPI) for diphtheria, pertussis (whooping cough), and tet-
anus (DPT), Haemophilus influenza type b, and Strepto-
coccus pneumoniae (7-valent pneumococcal conjugate
vaccine [PCV] from 2009, replaced with 13-valent PCV
in 2011).
Sample collection
Two paired induced sputa and a nasopharyngeal (NP)
swab specimens were collected from each child and
transported to the laboratory within 2 h of collection.
NP swabs were obtained before sputum induction using
nylon flocked swabs (Copan Italia, Brescia, Italy) by
trained study staff [11]. Each NP swab was immediately
placed into 1.5 ml PrimeStore® transport and stabilization
medium (PrimeStore® MTM, Longhorn Vaccines and
Diagnostics, San Antonio, TX) and stored at −80 °C within
2 h of collection until further batch processing. Samples
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were randomly selected from a convenience subset of
214 children, over a 1-year period for testing of NP
specimens for other microbes.
As the volume obtained on induced sputum specimens
was small, the entire specimen was required for detec-
tion of M tuberculosis, for optimal management and as
this study was nested within a broader study investigat-
ing better diagnostics for TB in children [11]. We did
not want to compromise this primary aim and only NP
samples were available for study of other respiratory
pathogens.
Diagnosis of PTB
Induced sputum specimens were submitted to the
National Health Laboratory Services (NHLS) Medical
Microbiology Laboratory at Groote Schuur Hospital
(Cape Town, South Africa) for mycobacterial liquid cul-
ture (BACTEC MGIT, Becton Dickinson Microbiology
Systems, Cockeysville, MD) and nucleic acid amplifica-
tion testing (Xpert MTB/RIF, Cepheid, Sunnyvale, CA).
Children were categorised as ‘definite-TB’ (i.e. culture
or Xpert MTB/RIF positive for M. tuberculosis), ‘unlikely
TB’ (i.e. no clinical diagnosis of TB with improvement
on follow-up without TB treatment) and ‘unconfirmed
TB’ (all others) [12].
Multiplex PCR testing of nasopharyngeal samples
NP swabs were thawed at room temperature (22 °C) and
vortexed for 15 s. Thereafter, 400 μl of each sample was
transferred to a ZR BashingBeadsTM Lysis tube (Zymo
Research Corp., Irvine, CA) and subjected to mechanical
lysis on a Tissuelyzer LT (Qiagen, Hilden, Germany)
[13]. The lysed samples were then centrifuged at
10,000 × g for 1 min to pellet all cellular debris. Ali-
quots of 250 μl of the supernatant were transferred
to a 2 ml sterile tube (Sarstedt, Nümbrecht, Germany)
and 4 μl of an exogenous internal control (Equine arteritis
virus) was added to each sample prior to automated total
nucleic acid extraction on the QIAsymphony SP instru-
ment using the QIAsymphony® Virus/Bacteria mini kit
(Qiagen, Hilden, Germany). Total nucleic acid was eluted
in 60 μl elution buffer and stored at -80 °C until further
processing.
Nucleic acid amplification was performed using the
FTD Resp33 kit according to the manufacturer’s instruc-
tions (Fast-track Diagnostics, Luxembourg). The assay
comprises eight multiplex real-time PCR reactions for
the detection of nucleic acid targets (Additional file 1:
Table S1).
Results were interpreted according to manufacturer’s
instructions using the FTD resp33 Analyser, an in-house
JAVA based program (available at http://www.gematics.
com/analyser.html).
Statistical analysis
Exploratory statistics were performed using STATA soft-
ware (Stata Corporation, College Station, TX), whilst the
openly available statistical environment R, version 3.1.1
[14] was used for more detailed analyses. Pearson’s Chi-
squared test was used to compare the occurrence of
each microbe between children with definite TB and un-
likely TB with Yates’ continuity correction. Permutation
tests were used to determine which microbe pairs were
statistically concurrent. Briefly, for each pair of mi-
crobes, X and Y, the observed number of concurrences
(m) was counted. The null hypothesis was that there was
no relationship between microbes X and Y and that the
co-occurrences were purely random. The null hypothesis
was tested by generating random permutations of the
occurrences of X and Y. The number of concurrences
under these random conditions was then counted, m1.
By repeating the permutation process 10 000 times, 10
000 random concurrences were obtained as follows: m1,
m2,…, m10000. The shape of the null-distribution, the dis-
tribution of co-occurrence counts under purely random
conditions, was estimated from the 10 000 observed
values of the permutation test. The achieved significance
level (ASL) was computed as the number of permuted
co-occurrences that were equal to or greater than the
observed number of concurrence (tail probability under
the null-distribution). This can be interpreted as a non-
parametric p-value [15].
Linear Discriminant Analysis (LDA) and Quadratic
Discriminant Analysis (QDA) [16] were used to opti-
mally discriminate respiratory microbes occurring in
relation to TB status. The LDA is visually represented in
a Canonical Variate Analysis (CVA) biplot and the QDA
in a QDA biplot [16]. The visualizations provide infor-
mation on how the different TB groups overlap and to
what extent the detection of microbes differs between
the groups. For all the tests, a p-value less than 0.05 was
used as the limit of statistical significance.
Ethical considerations
The Human Research Ethics Committee (HREC 045/
2008) of the Faculty of Health Sciences, University of
Cape Town, South Africa approved this study.
Results
Table 1 summarises the baseline characteristics of the
214 children included in this study. The median age of
the study participants was 36 months (interquartile
range, [IQR] 19–66 months). Children with definite-TB
were older (p = 0.003) than children with unconfirmed
TB or unlikely TB. Thirty-four (16 %) of the 214 chil-
dren had culture confirmed TB, while 86/214 (40 %) had
unconfirmed-TB and 94/214 (44 %) were categorised
as unlikely TB. Only 13 % (27/214) of children were
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HIV-infected, with similar HIV prevalence by TB cat-
egory. Immunization records were available for 162 out of
214 (76 %) children included in this study. Among
children for whom data on immunization profile was
available, the vaccination status was up to date in 78 % of
children, while among the remaining 22 % (36/162), at
least one scheduled immunization was missing. None of
the risk factors considered in Table 1 was associated
with the occurrence of any microbes pertussis even
after adjusting for potential confounders (Additional
file 1: Table S3).
Microbes detected in nasopharyngeal samples
Nucleic acid of at least one of the 33 targeted respiratory
microbes was detected in 97 % of 214 NP specimens.
The most common bacteria detected were Moraxella cat-
arrhalis (64 %), S. pneumoniae (42 %), H. influenzae spp
(29 %) and Staphylococcus aureus (22 %) (Table 2). M.
pneumoniae (9 %), B. pertussis (7 %) or C. pneumoniae
(4 %) were detected less frequently. The most frequently
detected viral targets were human metapneumovirus
(hMPV) (19 %), rhinovirus (15 %), influenza C virus (9 %),
adenovirus (7 %), cytomegalovirus (7 %) and coronavirus
O43 (5.6 %) (Table 2).
Seasonal patterns were observed for hMPV, rhino-
virus, enterovirus and influenza viruses with peak
prevalence in late winter (August) and spring (November).
In addition, a seasonal pattern was detected for tuber-
culosis (Additional file 1: Figure S1). No distinct seasonal
patterns were observed for other microbes.
A single bacterial target was detected in 39/214
(18 %) of samples tested. Two bacterial targets were
detected in 53/214 (25 %), and three bacterial targets
detected in 111/214 (52 %). A single viral target was
detected in 71/214 (33 %) of samples, two viral tar-
gets in 47/214 (22 %) and three or more viral targets
in 10/214 (5 %) specimens. Bacteria alone were de-
tected in 86/214 (40 %) of samples, viruses alone
were detected in 11/214 (5 %) of samples and both
viruses and bacteria in 117/214 (55 %) of samples. A
detailed overview of all possible pairs of co-occuring
respiratory microbes, irrespective of TB category
(Additional file 1: Table S2). These co-occurences were
further tested for significance (Table 3). Significant
bacterial-bacterial associations included interactions
between M. catarrhalis and each of M. pneumoniae, S.
pneumoniae and H. influenza spp. Viral-viral associa-
tions included: bocavirus and influenza A virus, para-
influenza 1 virus and coronavirus NL63 as well as
hMPV and enterovirus. Significant viral - bacterial asso-
ciations were common particularly between H. influenza
(type b or non-type b) and a range of viruses, includ-
ing enteroviruses, hMPV, influenza C, influenza A and
cytomegalovirus.
Table 1 Baseline characteristics of the children in the study by TB category
Characteristics Total (n = 214) Definite-TB (n = 34) Unconfirmed-TB (n = 86) Unlikely-TB (n = 94) p-value
Age in months, median (IQR) 36 (19–66) 56 (23–109) 34 (15–63) 32 (17–63) 0.003
Sex: female, n (%) 109 (51) 14 (41) 45 (52) 50 (53) 0.03
HIV infection, n (%) 27 (13) 7 (21) 13 (15) 7 (7) 0.14
HIV WHO clinical staging, n (%)
Stage 1 0 0 0 0 -
Stage 2 0 0 0 0 -
Stage 3 21 (10) 5 (15) 10 (12) 6 (6) 0.36
Stage 4 6 (3) 2 (6) 3 (35) 1 (1) 0.48
Smoking: yes, n (%) 29 (14) 5 (15) 12 (14) 12 (13) 0.56
Night sweats: yes, n (%) 118 (55) 15 (44) 57 (66) 46 (49) 0.61
Fever: yes, n (%) 102 (48) 13 (38) 52 (60) 37 (39) 0.19
Malaise: yes, n (%) 62 (29) 14 (41) 30 (35) 18 (19) 0.88
Cough: yes, n (%) 165 (77) 27 (79) 67 (78) 71 (76) 0.61
Appetite loss: yes, n (%) 110 (51) 18 (53) 43 (50) 48 (51) 0.69
Weight loss: yes, n (%) 133 (62) 23 (68) 63 (73) 47 (50) 0.07
Vomiting: yes, n (%) 43 (20) 7 (21) 19 (22) 17 (18) 0.73
BMI, median (IQR) 16 (15–18) 15 (14–17) 15 (14–17) 16 (15–18) 0.26
Hypoxia, median (IQR) 99 (97–100) 98 (97–99) 99 (97–100) 100 (97–100) 0.63
Chest in drawing: yes, n (%) 20 (9) 5 (15) 10 (12) 5 (5) 0.08
Respiratory rate, median (IQR) 34 (31–40) 35 (30–40) 35 (30–40) 34 (32–40) 0.68
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Microbial target detection by TB category
Both bacterial and viral targets were detected in 24/34
(71 %), 52/94 (55 %) and 48/86 (56 %) of NP specimens
from children with definite-TB, unconfirmed-TB and
unlikely-TB groups, respectively. There were no sig-
nificant differences in the distribution of individual
pathogens (Table 2) by TB category. However, visual
inspection of the CVA biplot for graphical visualisation
Table 2 Respiratory microbes detected from children presenting with suspected pulmonary tuberculosisa
Total n (%) cTB status n (%) Unadjasted p-value #Adjusted p-value
Definite-TB Unconfirmed-TB Unlikely-TB
Number of participants 214 (100) 34 (16) 86 (40) 94 (44)
Bacteria
M. catarrhalis 137 (64) 24 (71) 56 (65) 57 (60) 0.64 1.00
S. pneumoniae 90 (42) 18 (53) 38 (44) 34 (36) 0.22 1.00
H. influenzae spp 62 (29) 8 (24) 25 (29) 29 (31) 0.44 1.00
S. aureus 47 (22) 7 (21) 18 (21) 22 (23) 0.79 1.00
H. influenzae B 31 (15) 5 (15) 15 (17) 11 (12) 0.97 1.00
M. pneumoniae 19 (9) 2 (6) 9 (10) 8 (9) 0.84 1.00
B. pertussis 12 (6) 3 (9) 6 (7) 3 (3) 0.43 1.00
C. pneumoniae 9 (4) 4 (12) 4 (5) 1 (1) 0.03 0.42
Viruses
Metapneumovirus A/B 41 (19) 7 (21) 21 (24) 13 (14) 0.60 1.00
Rhinovirus 31 (15) 6 (18) 13 (15) 12 (13) 0.77 1.00
Enterovirus 22 (10) 1 (3) 10 (12) 11 (12) 0.21 1.00
Adenovirus 14 (7) 3 (9) 5 (6) 6 (6) 0.99 1.00
Cytomegalovirus 14 (7) 3 (9) 3 (3) 8 (9) 1.00 1.00
Bocavirus 14 (7) 8 (24) 1 (1) 5 (5) 1.00 1.00
Coronavirus 17 (8) 5 (15) 8 (9) 4 (4) 0.13 0.94
Coronavirus O43 12 (6) 5 (15) 5 (6) 2 (2) 0.02 0.42
Coronavirus HKU 2 (1) 0 (0) 1 (1) 1 (1) 1.00 1.00
Coronavirus NL63 2 (1) 0 (0) 1 (1) 1 (1) 1.00 1.00
Coronavirus 229E 1 (0.5) 0 (0) 1 (1) 0 (0) nad nad
RSV A/Bb 7 (3) 1 (3) 3 (3) 3 (3) 1.00 1.00
Influenza virus 33 (15) 8 (24) 15 (17) 10 (11) 0.17 0.94
Influenza A 7 (3) 1 (3) 4 (5) 2 (2) 1.00 1.00
Influenza B 7 (3) 1 (3) 2 (2) 4 (4) 1.00 1.00
Influenza C 19 (9) 6 (18) 9 (10) 4 (4) 0.04 0.43
Parainfluenza virus 10 (5) 1 (3) 4 (5) 5 (5) 0.88 1.00
Parainfluenza 1 5 (2) 1 (3) 2 (2) 2 (2) 1.00 1.00
Parainfluenza 2 1 (0.5) 0 (0) 0 (0) 1 (1) 1.00 1.00
Parainfluenza 3 2 (1) 0 (0) 1 (1) 1 (1) 1.00 1.00
Parainfluenza 4 2 (1) 0 (0) 1 (1) 1 (1) 1.00 1.00
Both Bacteria & Viruses 124 (58) 24 (73) 48 (56) 52 (55) - 0.11
Fungi
P. jirovecii 23 (11) 3 (9) 10 (12) 10 (11) 0.94 1.00
aArranged in order of decreasing colonisation or detection rates
bRSV A/B = Respiratory Syncyntial virus A and B
#The adjusted p-value compensates for multiple comparisons. The p-values only compare the presence of each microbe between the definite-TB and unlikely-TB
groups. The true proportion of TB in the unconfirmed-TB is unknown hence not included in comparison
cTB =Microbiological confirmation of pulmonary Tuberculosis
nad = Non of the children had Coronavirus 229 present, except in the unconfirmed-TB category which is excluded
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Table 3 Summary of significance level for all paired microbe co-occurrencesc
Influenza
A
Rhinovirus Influenza
B
Parainfuenza
3
Parainfuenza
2
Parainfuenza
4
Coronavirus
29
Coronavirus
63
Coronavirus
43
Coronavirus
HK
RSV A/Ba Cytomegalovirus Adenovirus
Rhinovirus 1
Influenza B 1 1
Parainfuenza 3 1 0.27 1
Parainfuenza 2 1 0.14 1 1
Parainfuenza 4 1 0.27 1 1 1
Coronavirus 229 1 1 1 1 1 1
Coronavirus 63 1 1 1 1 1 1 1
Coronavirus 43 1 0.56 0.33 1 1 1 1 1
Coronavirus 0.07 1 1 1 1 1 1 1 1
RSV A/Ba 1 0.66 1 1 1 1 1 1 1 1
Cytomegalovirus 0.07 1 1 1 1 1 0.07 1 0.57 0.12 1
Adenovirus 0.38 0.90 1 1 1 1 1 1 0.56 0.13 1 0.23
Enterovirus 1 0.08 0.54 1 1 0.20 1 1 1 1 1 0.80 0.16
Parainfluenza 1 1 1 1 1 1 1 1 0.04 0.25 1 1 1 1
HmPV A/Bb 0.78 0.57 0.78 0.3 1 1 1 1 0.41 1 1 0.27 0.79
M. pneumoniae 0.48 0.29 1 0.01 1 0.17 1 1 0.68 1 0.12 1 0.36
Bocavirus 0.02 0.33 1 1 1 1 1 1 1 0.08 0.24 1 0.42
S. aureus 1 0.72 0.83 1 1 0.39 1 1 0.79 1 0.82 0.37 0.97
C. pneumoniae 1 0.76 1 1 1 1 1 1 1 1 0.26 0.47 0.46
S. pneumoniae 0.11 0.09 0.62 1 1 0.67 1 1 0.19 0.67 0.98 0.18 0.77
H. influenzae B 1 0.69 1 1 1 0.27 1 1 0.85 1 1 0.63 0.12
P. jirovecii 0.55 0.44 0.55 1 1 1 1 0.21 0.38 0.01 0.55 0.46 0.81
M. cartarrhalis 0.51 0.07 0.21 0.42 1 0.88 1 0.41 0.03 0.87 0.51 0.38 0.97
Influenza C 1 0.79 1 1 1 1 1 1 0.30 1 0.12 1 0.75
H. influenzae spp 0.02 0.57 0.32 0.49 1 1 1 1 0.47 0.50 0.91 0.00 0.39
B. pertussis 1 0.54 0.33 1 1 1 1 1 0.51 1 1 1 1
aRSV A/B = Respiratory Syncyntial virus A and B, bHmPV A/B = Human Metapneumovirus A and B
cEach pair of microbe pairs were tested for concurrency and the table reports achieved significance levels (interpreted similar to a p-value) irrespective of the TB category. Significant concurrent relationships are
highlighted in bold
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Table 3 Summary of significance level for all paired microbe co-occurrencesc (Continued)
Enterovirus Parainfuenza 1 HmPV A/Bb M. pneumoniae Bocavirus S. aureus C. pneumoniae S. pneumoniae H. influenzae B P. jirovecii M. cartarrhalis Influenza C H. influenzae
spp
Rhinovirus
Influenza B
Parainfuenza 3
Parainfuenza 2
Parainfuenza 4
Coronavirus 229
Coronavirus 63
Coronavirus 43
Coronavirus
RSV A/Ba
Cytomegalovirus
Adenovirus
Enterovirus
Parainfluenza 1 1
HmPV A/Bb 0.01 1
M. pneumoniae 0.31 1 0.51
Bocavirus 0.58 1 0.82 1
S. aureus 0.08 1 0.26 0.83 0.25
C. pneumoniae 0.63 0.19 1 0.58 0.29 0.89
S. pneumoniae 0.63 0.94 0.03 0.76 0.73 0.28 0.99
H. influenzae B 0.02 1 0.75 0.04 1 0.36 0.76 0.43
P. jirovecii 0.72 1 0.68 0.63 0.60 0.00 1 0.70 0.00
M. cartarrhalis 0.05 0.95 0.06 0.01 1 0.81 0.94 0.00 0.71 0.72
Influenza C 0.61 0.06 0.91 0.02 0.53 1 0.19 1 0.00 0.63 0.45
H. influenzae spp 0.92 0.82 0.02 0.69 0.73 0.99 0.52 0.01 0.86 0.71 0.03 1
B. pertussis 0.12 1 0.93 0.29 1 1 0.41 0.94 0.00 1 0.13 0.00 0.48
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of LDA for all TB categories (Fig. 1) suggests that C. pneu-
moniae, S. pneumoniae, M. catarrhalis, coronavirus O43,
influenza virus C virus, rhinovirus, parainfluenza virus 1,
and adenovirus formed the dominant microbial profile in
definite-TB cases. In contrast, cytomegalovirus, influenza
B, parainfluenza virus 2, RSV A/B, S. aureus, H. influenzae
spp, and P. jirovecii associated with the unlikely-TB group.
When the unconfirmed TB group is excluded from the
LDA analysis, the LDA biplot is reduced to a one-
dimensional plot (Additional file 1: Figure S2). In this case,
the presence of rhinovirus, coronavirus 043, adenovirus,
parainfluenza 1, hMPV, bocavirus, C. pneumoniae, S.
pneumoniae, H. influenzae type b, M. catarrhalis, influ-
enza virus C virus, and B. pertussis best discriminated
cases with definite-TB from those with unlikely TB.
Quadratic Discriminent Analysis did not identify any
significant association between definite-TB and unlikely-
TB groups. However, visual inspection of the QDA
biplot (Fig. 2) showed that hMPV, coronavirus 043,
influenza C virus, rhinovirus, cytomegalovirus and C.
pneumoniae formed the dominant microbial profile as-
sociated with definite-TB cases. In contrast, M. pneumo-
niae, H. influenzae, P. jirovecii, enterovirus, influenza B
virus and RSV A/B were associated with the unlikely-TB
category.
Discussion
This is the first comprehensive detailed study of the
diversity of respiratory microbes detected in children
presenting with suspected PTB in a TB endemic setting
and showed that multiple potential pathogens are present
in th nasopharynx of such children.
The FTD33 multiplex real-time PCR detected at least
one of the 33 microbial targets in 97 % of NP swabs
Fig. 1 Canonical Variate Analysis (CVA) biplot for graphical visualisation of Linear Discriminant Analysis (LDA). This demonstrates the presence or
absence of respiratory microbes in the definite-TB (red squares), unconfirmed-TB (green squares) and unlikely-TB (blue squares) groups
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from children suspected of PTB. Detection of multiple
bacterial and viral targets was common. Bacterial species
frequently found as commensals in the nasopharynx
were most commonly detected [17, 18]. They include M.
catarrhalis (64 %), S. pneumoniae (42 %), H. influenzae
spp (29 %), and S. aureus (22 %). In addition, potential
pathogenic organisms were detected in the nasopharynx
including RSV, C. pneumoniae and B. pertussis.
The prevalence of B. pertussis was 6 % in our study.
Similar detection rates (1–9 %) were reported in other
South African settings in children with LRTI including
at our study site, 10–20 years post transition from
whole-cell vaccines to acellular vaccines (South African
infants are vaccinated with DTaP-IPV/HIB; Pentaxime®,
Sanofi Pasteur) [19].
The prevalence of some clinically relevant viral targets
(RSV, bocavirus and adenovirus) in this cohort is lower than
that previously reported in children with LRTI [20–22].
The observed differences may be explained by our enrol-
ment criteria which targeted symptoms suggestive of PTB.
However, viral PCR positivity of hMPV, enterovirus and in-
fluenza virus is similar to a recent case-control study that
also showed their association with community acquired
pneumonia [20]. As with bacteria, care needs to be taken
with the interpretation of molecular detection of some
viruses in NP specimens, since target nucleic acid may be
detected for some time after resolution of symptoms, and
from otherwise healthy children [23, 24].
In this study, some microbes showed no association
with any of the TB categories. These included M. catar-
rhalis, and S. pneumoniae. A randomised controlled trial
of the efficacy of PCV9 in South African children
showed decreased rates of culture-confirmed and clinic-
ally diagnosed TB in PCV9 recipients hospitalised with
LRTI compared with placebo recipients (relative risk re-
duction 43 %) [6]. This suggests that coinfection with M.
tuberculosis and S. pneumoniae causes severe infection
requiring hospitalization. Although common in our co-
hort, S. pneumoniae did not cluster together with the TB
or unlikely-TB groups, however we measured NP
colonization which is likely to be an inaccurate measure
for the contribution of S. pneumoniae to LRTI.
We have recently shown [5] that specific pathogens
(specifically B. pertussis, influenza virus, RSV, adeno-
virus, parainfluenzavirus, bocavirus) are detected signifi-
cantly more frequently from the NP of children with
pneumonia than age-matched controls. In this study we
detected all of these organisms, irrespective of TB-
classification, suggesting that these pathogens may play
a role in the exacerbation of symptoms in children with
Fig. 2 Quadratic Discriminant Analysis (QDA) biplot for graphical visualisation of microbe classification [16]. Clustering of respiratory microbes
in the definite-TB (red squares) and unlikely-TB (blue squares) groups is shown. Arrows indicate the presence of the microbes. *RSVAB = Respiratory
Syncytial virus A and B
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TB as well as accounting for the respiratory illness of a
subset of the children without TB.
Whilst we detected multiple significant co-occurrences
between different microbes in this study, these require
more detailed assessment in a larger group of children.
For example, the co-occurrence between M. catarrhalis,
S. pneumoniae and H. influenzae, may reflect age-specific
colonization patterns as previously reported [25, 26].
Other microbial co-occurrences, such as the association
between S. aureus and P. jorovecii, were unexpected. We
are currently conducting a larger, longitudinal study to
better understand these co-occurences [27].
We were unable to identify significant associations
between individual nasopharyngeal microbes and TB
classification. Discriminant analysis identified that the
presence of C. pneumoniae, hMPV, coronavirus O43,
influenza C virus, rhinovirus and cytomegalovirus best
discriminated children with definite TB. The significance
of co-detection of these microbes in children with TB is
unclear, and needs to be further assessed. One possibility
is that the relative immune suppression or lung path-
ology associated with PTB may render the host sus-
ceptible to other respiratory infections, or alternatively,
that intercurrent infection may be immunosuppressive,
predisposing to an accelerated clinical course or likeli-
hood of symptoms in children with PTB. Active TB is
associated with suppression of cellular immune re-
sponses, which are critical for the control of intracellular
infections [28] such as many of those associated with
definite TB in this study. However, in this study, individ-
ual microbes were each only detected in small numbers
of children which limits our ability to draw firm conclu-
sions in this regard.
A recent South African study has shown an increased
risk of death in adults with TB-influenza A virus co-
infection (adjusted relative risk ratio [aRRR] 6.1) com-
pared to TB infection alone [29]. In contrast, de Paus et
al. did not find a correlation between the seroprevalence
of influenza antibodies and the development of clinically
active TB in an Indonesian cohort [30]. They did how-
ever show an association between elevated antibody ti-
tres against influenza A and the clinical stage of TB lung
disease suggesting recent re-infection with influenza pre-
cedes clinical presentation with PTB [30].
A limitation of this study is the lack of a control group
of children without lower respiratory symptoms. We are
therefore unable to infer whether the pathogens detected
played a role in the development or exacerbation of
symptoms in this cohort. Further limitations include
sampling of the nasopharynx rather than the lower
respiratory tract, limiting the ability to infer causality for
lung co-pathogens. Klebsiella pneumoniae, Legionella
spp and Salmonella targets were excluded from analysis
due to problems with assay specificity for these targets.
Conclusion
In conclusion, this study describes the detection of mul-
tiple respiratory microbes in the nasopharynx of children
hospitalised with suspected PTB. Whilst there was no
clear separation between the pathogens present in the
airways of children with and without PTB, C. pneumoniae,
hMPV, coronavirus O43, influenza C virus, rhinovirus and
cytomegalovirus formed the dominant microbial profile in
children with PTB but this failed to reach statistical sig-
nificance on testing of each individual microbe. In con-
trast, P. jirovecii, H. influenzae spp, RSV, M. pneumoniae,
influenza B virus and enteroviruses were more consist-
ently detected in children without TB although not statis-
tically significant. This pilot work may signal broader
differences in the microbial ecology of the upper respira-
tory tract of these children, which warrants further study.
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